pharmaceutical-investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical-investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Rio Silver Launches Metallurgical Program to De-Risk Processing and Optimize Silver Recoveries at Maria Norte